Phase 1 study, condition: Obesity. The main purpose of the study is to look at the effect of the study drug compared to placebo on calorie intake, energy metabolism, and appetite. The study will last up to 6 months and may include up to 20 visits. Enrolment: 85 participants. Status: completed. No topline or peer-reviewed results are verified for publication on this Record for this study — registry facts only.
Checked 2026-08-08 · next review due 2026-11-08
← Back to the Record